Search
Publication
Communicable disease threats report, 6-11 March 2022, week 10
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-11 March 2022, and includes updates on COVID-19, rat hepatitis E, seasonal influenza, measles, Japanese encephalitis, polio, MERS-CoV, dengue, chikungunya and the influx of people displaced from Ukraine to the EU following Russia's invasion of Ukraine.
Enhancing Preparedness for Arbovirus Infections with a One Health Approach: The Development and Implementation of Multisectoral Risk Assessment Exercises
Peer-Reviewed Publication
Dente, M.G., Riccardo, F., Van Bortel, W., Marrama, L., Mollet, T., Derrough, T., Sudre, B., Calistri, P., Nacca, G., Ranghiasci, A., Escadafal, C., Gaayeb, L., Guillot, A., Jiménez-Clavero, M.A., Manuguerra, J.-C., Mikaty, G., Picard, M., Fernández-Pinero, J., Pérez-Ramírez, E., Robert, V., Victoir, K., Declich, S.
Increased risk for autochthonous vector-borne infections transmitted by Aedes albopictus in continental Europe
Peer-Reviewed Publication
Gossner, C.M., Ducheyne, E., Schaffner, F.
- Africa
- Albania
- Americas
- Asia
- Brazil
- Bulgaria
- Chikungunya virus disease
- Croatia
- Dengue
- Epidemic
- Europe
- France
- Germany
- Italy
- Japanese encephalitis virus
- La Réunion
- Netherlands
- Pacific regions
- Portugal
- Prevention and control
- Public health threat
- Romania
- Spain
- Surveillance
- United Kingdom
- Vector-borne disease
- West Nile virus infection
- Yellow fever
- Zika virus disease
Status, quality and specific needs of Zika virus (ZIKV) diagnostic capacity and capability in National Reference Laboratories for arboviruses in 30 EU/EEA countries, MAY 2016
Peer-Reviewed Publication
Mögling, R., Zeller, H., Revez, J., Koopmans, M., Reusken, C., Aberle, S., Van Esbroeck, M., Christova, I., Vilibic-Cavlek, T., Richter, J., Zelena, H., Fomsgaard, A., Jaaskelainen, A.J., Brichler, S., Illiaquer, M., Gonfrier, G., Leparc-Goffart, I., Poveda, J.-D., Hober, D., Fleury, H., Fafi-Kremer, S., Foulongne, V., Henquell, C., Leveque, N., Carles, M.J., Mansuy, J.M., Schmidt-Chanasit, J., Nitsche, A., Papa, A., Mentis, A., Takacs, M., Love, A., Connell, J., Venturi, G., Storoženko, J., Griskevicius, A., Opp, M., Barbara, C., Reusken, C., Reimerink, J., Dudman, S.G., Pancer, K., Alves, M.J., Ceianu, C.S., Ticha, E., Županc, T.A., Sanchez-Seco, M.P., Tolfvenstam, T., Aarons, E.
Prevention and control measures of Japanese encephalitis
Different kinds of vaccines (inactivated, attenuated and chimeric) are available and used in several Asiatic countries. In Europe an inactivated vaccine is currently available. Another way of prevention is avoiding mosquito bites.
Factsheet about Japanese encephalitis
Japanese encephalitis virus is present in Asia and Oceania, from Japan to India, Pakistan and Australia. Outbreaks are erratic and spatially and temporally limited phenomena, occurring quite unpredictably. The virus is a leading cause of viral encephalitis in Asia, with 30 000 to 50 000 cases reported annually.